Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
In April 2023, 23andMe was targeted in a hack that exposed the personal data of 6.9 million customers. The company agreed to ...
Me restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while ...
In addition to workforce reductions, 23andMe has also decided to discontinue its therapeutic ... The situation worsened in ...
In another blow to the company, seven of 23andMe’s eight-strong board resigned in September. The firm's independent directors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback